feeling lightheaded on semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide - Renew Body Wellness

However, the case suggests that clinicians should pay attention to potential visual impairments after acute improvement of glycemic control by incretin-related drugs, including tirzepatide

MASLD (metabolic dysfunction-associated steatotic liver disease) is what most people know as "fatty liver." It means excess fat has built up in the liver, which over time can cause inflammation, scarring, and serious liver damage

GLP-1 medications like semaglutide are non-habit-forming and target local appetite pathways with fewer systemic effects

Diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood

Once the dose wears off or treatment stops, metabolism and appetite rebound together, which partly explains why weight returns

Adems, su accin en el sistema digestivo ayuda a que las personas se sientan llenas con menos comida, lo que puede traducirse en una menor ingesta calrica diaria